NeuroSAFE PPI Day 2022

On the 29th of September 2022, the NeuroSAFE PROOF clinical research team conducted their second virtual Public & Patient Involvement (PPI) Session, talking to over 50 men with prostate cancer, as well as funder representative and member of the study site teams. A recording of the event can be watched below.

For more information on the event, please feel free to take a look here